| Application no. and date | 16718016.5 (espacenet) (Federated) (European Patent Register), 20160413 | | Patent/reg. no. and date | DK/EP 3286176, 20200115 | | Publication date | 20180228 | | Priority no. and date | US 201562152108 P, 20150424 | | EP pub. no. and date |
EP 3286176 20180228 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | P82000073DK00E | | Inventor | HANSEN, Eric Christian, 44 Renee Drive
Pawcatuck, Connecticut 06379, US,
SEADEEK, Christopher Scott, 3350 Whirlaway Court
West Lafayette, Indiana 47906, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | C07D 401/04 (2006.01) | | Title | KRYSTALLINSKE FORMER AF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREAMALEAT | | Int. application no. | IB2016052107 | | Int. publication no. | WO2016170451 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
